Skip to main content
Equibles

Charles Newton

Board Member

Keros Therapeutics, Inc. (KROS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Keros Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get KROS alerts

About Charles Newton

Charles Newton is recorded as Board Member at Keros Therapeutics, Inc. (KROS) since March 9, 2026. Keros Therapeutics, Inc. reported in an 8-K filed February 26, 2026 that Charles Newton was appointed director, effective March 9, 2026. Keros Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Keros Therapeutics, Inc. includes Jasbir Seehra (CEO, Chairman and Board Member), Jean-Jacques Bienaimé (Chairman and Board Member), Annita Tanini (Chief Accounting Officer) and 3 others.

“On February 24, 2026, the board of directors (the "Board") of Keros Therapeutics, Inc. (the "Company"), based upon a recommendation from the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), voted to appoint Charles Newton as a director of the Company, effective on March 9, 2026.”
Keros Therapeutics, Inc. Form 8-K, filed February 26, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Keros Therapeutics, Inc.

Recent activity